NEWS: 公告在東京證券交易所JASDAQ標準市場新上市

表紙
市場調查報告書

基因編輯的全球市場:2020年∼2024年

Global Genome Editing Market 2020-2024

出版商 TechNavio (Infiniti Research Ltd.) 商品編碼 973463
出版日期 內容資訊 英文 120 Pages
訂單完成後即時交付
價格
基因編輯的全球市場:2020年∼2024年 Global Genome Editing Market 2020-2024
出版日期: 2020年11月12日內容資訊: 英文 120 Pages
簡介

全球基因編輯的市場規模在2020年∼2024年間,預測將成長到48億美元,在預測期間中預計將以17%的年複合成長率增長。

市場成長的主要因素有基因編輯應用的增加和基因改造農作物的需求增加。

本報告提供基因編輯的世界市場調查,提供市場形勢和規模,波特的五力分析,各終端用戶的市場區隔,客戶和各地區形勢,業者情勢,供應商分析等資訊。

目錄

摘要整理

市場形勢

市場規模

  • 市場定義
  • 市場區隔分析
  • 2019年的市場規模
  • 市場預測:從2019年∼2024年的預測

波特的五力分析

市場區隔:各終端用戶

  • 市場區隔
  • 各終端用戶比較
  • 製藥·生物科技企業:市場規模與預測(2019年∼2024年)
  • 學術·研究機關:市場規模與預測(2019年∼2024年)
  • CRO(臨床研究委外機構):市場規模與預測(2019年∼2024年)
  • 各終端用戶市場機會

客戶形勢

各地區形勢

  • 各地區市場區隔
  • 各地區比較
  • 北美:市場規模與預測(2019年∼2024年)
  • 歐洲:市場規模與預測(2019年∼2024年)
  • 亞洲:市場規模與預測(2019年∼2024年)
  • 其他地區:市場規模與預測(2019年∼2024年)
  • 主要國家
  • 各地區的市場機會
  • 市場推動因素
  • 市場課題
  • 市場趨勢

業者情勢

  • 業者情勢
  • 創造性破壞狀況
  • 競爭模式

供應商分析

  • 交易廠商
  • 供應商的市場定位
  • Eurofins Scientific SE
  • GenScript Biotech Corp.
  • Horizon Discovery Group Plc
  • Integrated DNA Technologies Inc.
  • Lonza Group Ltd.
  • Merck KGaA
  • New England Biolabs Inc.
  • Precision BioSciences Inc.
  • Sangamo Therapeutics Inc.
  • Thermo Fisher Scientific Inc.

附錄

目錄
Product Code: IRTNTR45678

Technavio has been monitoring the genome editing market and it is poised to grow by $ 4.8 bn during 2020-2024, progressing at a CAGR of 17% during the forecast period. Our reports on genome editing market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment. The market is driven by the increasing applications of genome editing and the increasing demand for genetically edited crops. In addition, increasing applications of genome editing is anticipated to boost the growth of the market as well.

The genome editing market analysis includes the end-user segment and geographical landscapes.

Technavio's genome editing market is segmented as below:

By End-user

  • Pharmaceutical and biotechnology companies
  • Academic institute and research laboratories
  • CROs

By Geographical Landscapes

  • North America
  • Europe
  • Asia
  • ROW

This study identifies an increase in human genomics research as one of the prime reasons driving the genome editing market growth during the next few years.

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters. Our genome editing market covers the following areas:

  • Genome editing market sizing
  • Genome editing market forecast
  • Genome editing market industry analysis

Technavio's robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading genome editing market vendors that include Eurofins Scientific SE, GenScript Biotech Corp., Horizon Discovery Group Plc, Integrated DNA Technologies Inc., Lonza Group Ltd., Merck KGaA, New England Biolabs Inc., Precision BioSciences Inc., Sangamo Therapeutics Inc., and Thermo Fisher Scientific Inc. Also, the genome editing market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage on all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. Technavio's market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast an accurate market growth.

Table of Contents

Executive Summary

  • Market Overview

Market Landscape

  • Market ecosystem
  • Value chain analysis

Market Sizing

  • Market definition
  • Market segment analysis
  • Market size 2019
  • Market outlook: Forecast for 2019 - 2024

Five Forces Analysis

  • Five forces summary
  • Bargaining power of buyers
  • Bargaining power of suppliers
  • Threat of new entrants
  • Threat of substitutes
  • Threat of rivalry
  • Market condition

Market Segmentation by End-user

  • Market segments
  • Comparison by End-user
  • Pharmaceutical and biotechnology companies - Market size and forecast 2019-2024
  • Academic institute and research laboratories - Market size and forecast 2019-2024
  • CROs - Market size and forecast 2019-2024
  • Market opportunity by End-user

Customer Landscape

Geographic Landscape

  • Geographic segmentation
  • Geographic comparison
  • North America - Market size and forecast 2019-2024
  • Europe - Market size and forecast 2019-2024
  • Asia - Market size and forecast 2019-2024
  • ROW - Market size and forecast 2019-2024
  • Key leading countries
  • Market opportunity by geography
  • Market drivers
  • Market challenges
  • Market trends

Vendor Landscape

  • Vendor landscape
  • Landscape disruption
  • Competitive scenario

Vendor Analysis

  • Vendors covered
  • Market positioning of vendors
  • Eurofins Scientific SE
  • GenScript Biotech Corp.
  • Horizon Discovery Group Plc
  • Integrated DNA Technologies Inc.
  • Lonza Group Ltd.
  • Merck KGaA
  • New England Biolabs Inc.
  • Precision BioSciences Inc.
  • Sangamo Therapeutics Inc.
  • Thermo Fisher Scientific Inc.

Appendix

  • Scope of the report
  • Currency conversion rates for US$
  • Research methodology
  • List of abbreviations

Exhibit

  • 1: Key Finding 1
  • 2: Key Finding 2
  • 3: Key Finding 3
  • 4: Key Finding 5
  • 5: Key Finding 6
  • 6: Key Finding 7
  • 7: Key Finding 8
  • 8: Parent market
  • 9: Market characteristics
  • 10: Offerings of vendors included in the market definition
  • 11: Market segments
  • 12: Global - Market size and forecast 2019 - 2024 ($ million)
  • 13: Global market: Year-over-year growth 2019 - 2024 (%)
  • 14: Five forces analysis 2019 & 2024
  • 15: Bargaining power of buyers
  • 16: Bargaining power of suppliers
  • 17: Threat of new entrants
  • 18: Threat of substitutes
  • 19: Threat of rivalry
  • 20: Market condition - Five forces 2019
  • 21: End user - Market share 2019-2024 (%)
  • 22: Comparison by End user
  • 23: Pharmaceutical and biotechnology companies - Market size and forecast 2019-2024 ($ million)
  • 24: Pharmaceutical and biotechnology companies - Year-over-year growth 2019-2024 (%)
  • 25: Academic institute and research laboratories - Market size and forecast 2019-2024 ($ million)
  • 26: Academic institute and research laboratories - Year-over-year growth 2019-2024 (%)
  • 27: CROs - Market size and forecast 2019-2024 ($ million)
  • 28: CROs - Year-over-year growth 2019-2024 (%)
  • 29: Market opportunity by End user
  • 30: Customer landscape
  • 31: Market share by geography 2019-2024 (%)
  • 32: Geographic comparison
  • 33: North America - Market size and forecast 2019-2024 ($ million)
  • 34: North America - Year-over-year growth 2019-2024 (%)
  • 35: Europe - Market size and forecast 2019-2024 ($ million)
  • 36: Europe - Year-over-year growth 2019-2024 (%)
  • 37: Asia - Market size and forecast 2019-2024 ($ million)
  • 38: Asia - Year-over-year growth 2019-2024 (%)
  • 39: ROW - Market size and forecast 2019-2024 ($ million)
  • 40: ROW - Year-over-year growth 2019-2024 (%)
  • 41: Key leading countries
  • 42: Market opportunity by geography ($ million)
  • 43: Impact of drivers and challenges
  • 44: Vendor landscape
  • 45: Landscape disruption
  • 46: Industry risks
  • 47: Vendors covered
  • 48: Market positioning of vendors
  • 49: Eurofins Scientific SE - Overview
  • 50: Eurofins Scientific SE - Business segments
  • 51: Eurofins Scientific SE - Key offerings
  • 52: Eurofins Scientific SE - Key customers
  • 53: Eurofins Scientific SE - Segment focus
  • 54: GenScript Biotech Corp. - Overview
  • 55: GenScript Biotech Corp. - Business segments
  • 56: GenScript Biotech Corp. - Key offerings
  • 57: GenScript Biotech Corp. - Key customers
  • 58: GenScript Biotech Corp. - Segment focus
  • 59: Horizon Discovery Group Plc - Overview
  • 60: Horizon Discovery Group Plc - Business segments
  • 61: Horizon Discovery Group Plc - Key offerings
  • 62: Horizon Discovery Group Plc - Key customers
  • 63: Horizon Discovery Group Plc - Segment focus
  • 64: Integrated DNA Technologies Inc. - Overview
  • 65: Integrated DNA Technologies Inc. - Product and service
  • 66: Integrated DNA Technologies Inc. - Key offerings
  • 67: Integrated DNA Technologies Inc. - Key customers
  • 68: Integrated DNA Technologies Inc. - Segment focus
  • 69: Lonza Group Ltd. - Overview
  • 70: Lonza Group Ltd. - Business segments
  • 71: Lonza Group Ltd. - Key offerings
  • 72: Lonza Group Ltd. - Key customers
  • 73: Lonza Group Ltd. - Segment focus
  • 74: Merck KGaA - Overview
  • 75: Merck KGaA - Business segments
  • 76: Merck KGaA - Key offerings
  • 77: Merck KGaA - Key customers
  • 78: Merck KGaA - Segment focus
  • 79: New England Biolabs Inc. - Overview
  • 80: New England Biolabs Inc. - Product and service
  • 81: New England Biolabs Inc. - Key offerings
  • 82: New England Biolabs Inc. - Key customers
  • 83: New England Biolabs Inc. - Segment focus
  • 84: Precision BioSciences Inc. - Overview
  • 85: Precision BioSciences Inc. - Business segments
  • 86: Precision BioSciences Inc. - Key offerings
  • 87: Precision BioSciences Inc. - Key customers
  • 88: Precision BioSciences Inc. - Segment focus
  • 89: Sangamo Therapeutics Inc. - Overview
  • 90: Sangamo Therapeutics Inc. - Product and service
  • 91: Sangamo Therapeutics Inc. - Key offerings
  • 92: Sangamo Therapeutics Inc. - Key customers
  • 93: Sangamo Therapeutics Inc. - Segment focus
  • 94: Thermo Fisher Scientific Inc. - Overview
  • 95: Thermo Fisher Scientific Inc. - Business segments
  • 96: Thermo Fisher Scientific Inc. - Key offerings
  • 97: Thermo Fisher Scientific Inc. - Key customers
  • 98: Thermo Fisher Scientific Inc. - Segment focus
  • 99: Currency conversion rates for US$
  • 100: Research Methodology
  • 101: Validation techniques employed for market sizing
  • 102: Information sources
  • 103: List of abbreviations